Coagulation Factors Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Factor VII, Factor VIII, Factor IX, Factor X, Factor XIII, Von Willebrand Factor, Anti-Inhibitor Coagulant Complex, Others); Application (Hemophilia, Von Willebrand disease (VWD), Surgery, Other Bleeding Disorders); Technology (Plasma derived, Recombinant); End User (Hospitals and Clinics, Ambulatory Surgery Centers, Research Institutes)

Report Code: TIPRE00021839 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Blood coagulation factors are proteins or enzymes that control bleeding. Blood coagulation or blood coagulation is a process in which blood gets converted into solid clots at time of any wound or break down of blood vessels. Coagulation can prevent death from bleeding and also restrict the entry of bacteria and viruses into the body. Haemostasias is the mechanism for blood coagulation, which in controlled by a number of factors called blood coagulation factors. Deficiency of these factors can cause blood coagulation diseases such as hemophilia and von Willebrand disease (VWD). According to Centre for disease control and prevention (CDC), 2020, around 20,000 males were suffering from Hemophilia in the U.S.

MARKET DYNAMICS

Coagulation factors market is driving due to factors such as approval of novel drugs, high prevalence of bleeding disorders and rising initiatives and donation for supporting the patients diagnosed with sever bleeding disorders like hemophilia. However, severe regulatory policies and a shortage in plasma supply are likely to create a negative impact on the growth of this market.

MARKET SCOPE

The Coagulation factors market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Coagulation factors Market with detailed market segmentation by product type, application, technology, and end user. The Coagulation factors Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Coagulation factors market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Coagulation factors market is segmented based on product type, application, technology, and end user. Based on product type, market is segmented as Factor VII, Factor VIII, Factor IX, Factor X, Factor XIII, Von Willebrand Factor, Anti-Inhibitor Coagulant Complex, Others. Based on application, market is segmented as Hemophilia, Von Willebrand disease (VWD), Surgery, Other Bleeding Disorders. Based on technology, market is segmented as Plasma derived, Recombinant. Based on end user, market is segmented as Hospitals and Clinics, Ambulatory Surgery Centers, Research Institutes.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Coagulation factors market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Coagulation factors market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Coagulation factors market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Coagulation factors market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Coagulation factors market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as Application and End user launches, Application and End user approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Coagulation factors market are anticipated to have lucrative growth opportunities in the future with the rising demand for Coagulation factors in the global market. Below mentioned is the list of few companies engaged in the Coagulation factors Market.

The report also includes the profiles of key players in Coagulation factors market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Shire Plc.
  •   Baxter International Inc.
  •   Grifols International SA
  •   Roche AG
  •   Bayer AG
  •   Pfizer Inc.
  •   Novo Nordisk A/S
  •   Octapharma AG
  •   Biogen Idec
  •   Kedrion S.P.A.
  •   CSL Ltd., Inc.
  •   RayBiotech, Inc.
  •   Biotest AG
  •   Diapharma
  •   Enzyme Research Laboratories Ltd.
  •   Catalyst Biosciences
  •   Molecular Innovations Inc.
  •   Bio Products Laboratory Ltd.
  •   Portola Pharmaceuticals

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Coagulation Factors Market - By Product Type
1.3.2 Coagulation Factors Market - By Application
1.3.3 Coagulation Factors Market - By Technology
1.3.4 Coagulation Factors Market - By End User
1.3.5 Coagulation Factors Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. COAGULATION FACTORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. COAGULATION FACTORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. COAGULATION FACTORS MARKET - GLOBAL MARKET ANALYSIS
6.1. COAGULATION FACTORS - GLOBAL MARKET OVERVIEW
6.2. COAGULATION FACTORS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. FACTOR VII
7.3.1. Overview
7.3.2. Factor VII Market Forecast and Analysis
7.4. FACTOR VIII
7.4.1. Overview
7.4.2. Factor VIII Market Forecast and Analysis
7.5. FACTOR IX
7.5.1. Overview
7.5.2. Factor IX Market Forecast and Analysis
7.6. FACTOR X
7.6.1. Overview
7.6.2. Factor X Market Forecast and Analysis
7.7. FACTOR XIII
7.7.1. Overview
7.7.2. Factor XIII Market Forecast and Analysis
7.8. VON WILLEBRAND FACTOR
7.8.1. Overview
7.8.2. Von Willebrand Factor Market Forecast and Analysis
7.9. ANTI-INHIBITOR COAGULANT COMPLEX
7.9.1. Overview
7.9.2. Anti-Inhibitor Coagulant Complex Market Forecast and Analysis
7.10. OTHERS
7.10.1. Overview
7.10.2. Others Market Forecast and Analysis
8. COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HEMOPHILIA
8.3.1. Overview
8.3.2. Hemophilia Market Forecast and Analysis
8.4. VON WILLEBRAND DISEASE (VWD)
8.4.1. Overview
8.4.2. Von Willebrand disease (VWD) Market Forecast and Analysis
8.5. SURGERY
8.5.1. Overview
8.5.2. Surgery Market Forecast and Analysis
8.6. OTHER BLEEDING DISORDERS
8.6.1. Overview
8.6.2. Other Bleeding Disorders Market Forecast and Analysis
9. COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
9.1. OVERVIEW
9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. PLASMA DERIVED
9.3.1. Overview
9.3.2. Plasma derived Market Forecast and Analysis
9.4. RECOMBINANT
9.4.1. Overview
9.4.2. Recombinant Market Forecast and Analysis
10. COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. AMBULATORY SURGERY CENTERS
10.4.1. Overview
10.4.2. Ambulatory Surgery Centers Market Forecast and Analysis
10.5. RESEARCH INSTITUTES
10.5.1. Overview
10.5.2. Research Institutes Market Forecast and Analysis
11. COAGULATION FACTORS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Coagulation Factors Market Overview
11.1.2 North America Coagulation Factors Market Forecasts and Analysis
11.1.3 North America Coagulation Factors Market Forecasts and Analysis - By Product Type
11.1.4 North America Coagulation Factors Market Forecasts and Analysis - By Application
11.1.5 North America Coagulation Factors Market Forecasts and Analysis - By Technology
11.1.6 North America Coagulation Factors Market Forecasts and Analysis - By End User
11.1.7 North America Coagulation Factors Market Forecasts and Analysis - By Countries
11.1.7.1 Mexico Coagulation Factors Market
11.1.7.1.1 Mexico Coagulation Factors Market by Product Type
11.1.7.1.2 Mexico Coagulation Factors Market by Application
11.1.7.1.3 Mexico Coagulation Factors Market by Technology
11.1.7.1.4 Mexico Coagulation Factors Market by End User
11.2. EUROPE
11.2.1 Europe Coagulation Factors Market Overview
11.2.2 Europe Coagulation Factors Market Forecasts and Analysis
11.2.3 Europe Coagulation Factors Market Forecasts and Analysis - By Product Type
11.2.4 Europe Coagulation Factors Market Forecasts and Analysis - By Application
11.2.5 Europe Coagulation Factors Market Forecasts and Analysis - By Technology
11.2.6 Europe Coagulation Factors Market Forecasts and Analysis - By End User
11.2.7 Europe Coagulation Factors Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Coagulation Factors Market
11.2.7.1.1 Germany Coagulation Factors Market by Product Type
11.2.7.1.2 Germany Coagulation Factors Market by Application
11.2.7.1.3 Germany Coagulation Factors Market by Technology
11.2.7.1.4 Germany Coagulation Factors Market by End User
11.2.7.2 France Coagulation Factors Market
11.2.7.2.1 France Coagulation Factors Market by Product Type
11.2.7.2.2 France Coagulation Factors Market by Application
11.2.7.2.3 France Coagulation Factors Market by Technology
11.2.7.2.4 France Coagulation Factors Market by End User
11.2.7.3 Italy Coagulation Factors Market
11.2.7.3.1 Italy Coagulation Factors Market by Product Type
11.2.7.3.2 Italy Coagulation Factors Market by Application
11.2.7.3.3 Italy Coagulation Factors Market by Technology
11.2.7.3.4 Italy Coagulation Factors Market by End User
11.2.7.4 Spain Coagulation Factors Market
11.2.7.4.1 Spain Coagulation Factors Market by Product Type
11.2.7.4.2 Spain Coagulation Factors Market by Application
11.2.7.4.3 Spain Coagulation Factors Market by Technology
11.2.7.4.4 Spain Coagulation Factors Market by End User
11.2.7.5 United Kingdom Coagulation Factors Market
11.2.7.5.1 United Kingdom Coagulation Factors Market by Product Type
11.2.7.5.2 United Kingdom Coagulation Factors Market by Application
11.2.7.5.3 United Kingdom Coagulation Factors Market by Technology
11.2.7.5.4 United Kingdom Coagulation Factors Market by End User
11.2.7.6 Rest of Europe Coagulation Factors Market
11.2.7.6.1 Rest of Europe Coagulation Factors Market by Product Type
11.2.7.6.2 Rest of Europe Coagulation Factors Market by Application
11.2.7.6.3 Rest of Europe Coagulation Factors Market by Technology
11.2.7.6.4 Rest of Europe Coagulation Factors Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Coagulation Factors Market Overview
11.3.2 Asia-Pacific Coagulation Factors Market Forecasts and Analysis
11.3.3 Asia-Pacific Coagulation Factors Market Forecasts and Analysis - By Product Type
11.3.4 Asia-Pacific Coagulation Factors Market Forecasts and Analysis - By Application
11.3.5 Asia-Pacific Coagulation Factors Market Forecasts and Analysis - By Technology
11.3.6 Asia-Pacific Coagulation Factors Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Coagulation Factors Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Coagulation Factors Market
11.3.7.1.1 Australia Coagulation Factors Market by Product Type
11.3.7.1.2 Australia Coagulation Factors Market by Application
11.3.7.1.3 Australia Coagulation Factors Market by Technology
11.3.7.1.4 Australia Coagulation Factors Market by End User
11.3.7.2 China Coagulation Factors Market
11.3.7.2.1 China Coagulation Factors Market by Product Type
11.3.7.2.2 China Coagulation Factors Market by Application
11.3.7.2.3 China Coagulation Factors Market by Technology
11.3.7.2.4 China Coagulation Factors Market by End User
11.3.7.3 India Coagulation Factors Market
11.3.7.3.1 India Coagulation Factors Market by Product Type
11.3.7.3.2 India Coagulation Factors Market by Application
11.3.7.3.3 India Coagulation Factors Market by Technology
11.3.7.3.4 India Coagulation Factors Market by End User
11.3.7.4 Japan Coagulation Factors Market
11.3.7.4.1 Japan Coagulation Factors Market by Product Type
11.3.7.4.2 Japan Coagulation Factors Market by Application
11.3.7.4.3 Japan Coagulation Factors Market by Technology
11.3.7.4.4 Japan Coagulation Factors Market by End User
11.3.7.5 South Korea Coagulation Factors Market
11.3.7.5.1 South Korea Coagulation Factors Market by Product Type
11.3.7.5.2 South Korea Coagulation Factors Market by Application
11.3.7.5.3 South Korea Coagulation Factors Market by Technology
11.3.7.5.4 South Korea Coagulation Factors Market by End User
11.3.7.6 Rest of Asia-Pacific Coagulation Factors Market
11.3.7.6.1 Rest of Asia-Pacific Coagulation Factors Market by Product Type
11.3.7.6.2 Rest of Asia-Pacific Coagulation Factors Market by Application
11.3.7.6.3 Rest of Asia-Pacific Coagulation Factors Market by Technology
11.3.7.6.4 Rest of Asia-Pacific Coagulation Factors Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Coagulation Factors Market Overview
11.4.2 Middle East and Africa Coagulation Factors Market Forecasts and Analysis
11.4.3 Middle East and Africa Coagulation Factors Market Forecasts and Analysis - By Product Type
11.4.4 Middle East and Africa Coagulation Factors Market Forecasts and Analysis - By Application
11.4.5 Middle East and Africa Coagulation Factors Market Forecasts and Analysis - By Technology
11.4.6 Middle East and Africa Coagulation Factors Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Coagulation Factors Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Coagulation Factors Market
11.4.7.1.1 South Africa Coagulation Factors Market by Product Type
11.4.7.1.2 South Africa Coagulation Factors Market by Application
11.4.7.1.3 South Africa Coagulation Factors Market by Technology
11.4.7.1.4 South Africa Coagulation Factors Market by End User
11.4.7.2 Saudi Arabia Coagulation Factors Market
11.4.7.2.1 Saudi Arabia Coagulation Factors Market by Product Type
11.4.7.2.2 Saudi Arabia Coagulation Factors Market by Application
11.4.7.2.3 Saudi Arabia Coagulation Factors Market by Technology
11.4.7.2.4 Saudi Arabia Coagulation Factors Market by End User
11.4.7.3 U.A.E Coagulation Factors Market
11.4.7.3.1 U.A.E Coagulation Factors Market by Product Type
11.4.7.3.2 U.A.E Coagulation Factors Market by Application
11.4.7.3.3 U.A.E Coagulation Factors Market by Technology
11.4.7.3.4 U.A.E Coagulation Factors Market by End User
11.4.7.4 Rest of Middle East and Africa Coagulation Factors Market
11.4.7.4.1 Rest of Middle East and Africa Coagulation Factors Market by Product Type
11.4.7.4.2 Rest of Middle East and Africa Coagulation Factors Market by Application
11.4.7.4.3 Rest of Middle East and Africa Coagulation Factors Market by Technology
11.4.7.4.4 Rest of Middle East and Africa Coagulation Factors Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Coagulation Factors Market Overview
11.5.2 South and Central America Coagulation Factors Market Forecasts and Analysis
11.5.3 South and Central America Coagulation Factors Market Forecasts and Analysis - By Product Type
11.5.4 South and Central America Coagulation Factors Market Forecasts and Analysis - By Application
11.5.5 South and Central America Coagulation Factors Market Forecasts and Analysis - By Technology
11.5.6 South and Central America Coagulation Factors Market Forecasts and Analysis - By End User
11.5.7 South and Central America Coagulation Factors Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Coagulation Factors Market
11.5.7.1.1 Brazil Coagulation Factors Market by Product Type
11.5.7.1.2 Brazil Coagulation Factors Market by Application
11.5.7.1.3 Brazil Coagulation Factors Market by Technology
11.5.7.1.4 Brazil Coagulation Factors Market by End User
11.5.7.2 Argentina Coagulation Factors Market
11.5.7.2.1 Argentina Coagulation Factors Market by Product Type
11.5.7.2.2 Argentina Coagulation Factors Market by Application
11.5.7.2.3 Argentina Coagulation Factors Market by Technology
11.5.7.2.4 Argentina Coagulation Factors Market by End User
11.5.7.3 Rest of South and Central America Coagulation Factors Market
11.5.7.3.1 Rest of South and Central America Coagulation Factors Market by Product Type
11.5.7.3.2 Rest of South and Central America Coagulation Factors Market by Application
11.5.7.3.3 Rest of South and Central America Coagulation Factors Market by Technology
11.5.7.3.4 Rest of South and Central America Coagulation Factors Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL COAGULATION FACTORS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. COAGULATION FACTORS MARKET, KEY COMPANY PROFILES
14.1. SHIRE PLC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. BAXTER INTERNATIONAL INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. GRIFOLS INTERNATIONAL SA
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. ROCHE AG
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BAYER AG
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. PFIZER INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. NOVO NORDISK A/S
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. OCTAPHARMA AG
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. BIOGEN IDEC
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. KEDRION S.P.A.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Shire Plc.
2. Baxter International Inc.
3. Grifols International SA
4. Roche AG
5. Bayer AG
6. Pfizer Inc.
7. Novo Nordisk A/S
8. Octapharma AG
9. Biogen Idec
10. Kedrion S.P.A.
11. CSL Ltd., Inc.
12. RayBiotech, Inc.
13. Biotest AG
14. Diapharma
15. Enzyme Research Laboratories Ltd.
16. Catalyst Biosciences
17. Molecular Innovations Inc.
18. Bio Products Laboratory Ltd.
19. Portola Pharmaceuticals
TIPRE00021839
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking